Staritas, backed by investment from Accel-KKR, will focus on healthcare supply chain data and artificial intelligence solutions.
ECRI has spun out its spend management and recall management solutions into an independent company called Staritas.
The launch of Staritas is supported by a growth investment from Accel-KKR, a technology-focused investment firm. The new entity will focus on healthcare supply chain intelligence through data-driven insights.
“For five decades, ECRI’s award-winning spend management solutions have helped healthcare supply chain leaders navigate supply disruptions with resiliency, save millions of dollars, and benchmark purchasing decisions using the industry’s most comprehensive, independent datasets,” says Marcus Schabacker, MD, chief executive officer and president of ECRI, in a release. “Now, by spinning out Staritas, powered by Accel-KKR to supercharge the power behind the data, improve the user experience, and accelerate innovation, healthcare supply chain leaders can realize even greater value from the platform.”
Staritas aims to develop and deliver artificial intelligence (AI) solutions to manage supply chain complexity. The company will use AI and healthcare supply and capital data, combined with analytics, to help organizations understand market trends and identify savings. According to the company, the tools—previously part of ECRI—have helped customers identify up to $13 billion in annual savings opportunities.
“Staritas is committed to providing data-driven insights and services that help healthcare organizations optimize operations, save money, and strengthen decision making,” says Emmet O’Gara, CEO of Staritas, in a release.
ECRI’s Focus
The spin-off allows ECRI to focus on patient safety, clinical evidence, and technology assessment, according to a press release. The organization remains a federally certified Patient Safety Organization by the United States Department of Health and Human Services.
“This move is not a departure; it is a commitment to deepening ECRI’s focus on patient safety, clinical evidence, and system-level change across healthcare,” says Schabacker in a release.
Dheerendra Kommala, MD, ECRI chief medical officer, notes that one in four patient admissions involve an adverse event, and nearly 25% of those are preventable.
“Through this strategic move, ECRI is now singularly focused on improving patient safety. We plan to expand solutions that can ‘transform’ healthcare organizations, building on our legacy of advancing evidence-based medicine,” says Kommala in a release.
ID 432662816 © Irochka | Dreamstime.com
